Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Mark Abzug

Concepts (408)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enterovirus Infections
21
2019
173
2.650
 Why?
HIV Infections
27
2022
3148
1.640
 Why?
Antiretroviral Therapy, Highly Active
9
2017
278
1.600
 Why?
Pneumococcal Vaccines
5
2021
129
1.570
 Why?
Antiviral Agents
12
2024
765
1.370
 Why?
Pregnancy Complications, Infectious
14
2015
431
1.280
 Why?
Enterovirus
9
2019
83
1.120
 Why?
Hematopoietic Stem Cell Transplantation
4
2021
677
0.920
 Why?
Immunologic Memory
3
2013
366
0.890
 Why?
Pneumococcal Infections
3
2013
103
0.860
 Why?
Immunization, Secondary
4
2021
92
0.850
 Why?
Oxadiazoles
4
2015
37
0.790
 Why?
Paralysis
4
2018
68
0.690
 Why?
Child
56
2024
22600
0.620
 Why?
Triazoles
3
2024
184
0.590
 Why?
Sinusitis
7
2013
227
0.550
 Why?
Mucositis
1
2018
20
0.550
 Why?
Anti-Retroviral Agents
8
2022
250
0.540
 Why?
Vaccination
4
2017
1419
0.530
 Why?
Meningoencephalitis
1
2017
24
0.530
 Why?
Candidiasis, Invasive
3
2024
6
0.520
 Why?
Antibodies, Bacterial
4
2013
146
0.510
 Why?
Myelitis
4
2019
107
0.510
 Why?
Influenza, Human
5
2015
618
0.500
 Why?
Theilovirus
4
2000
4
0.490
 Why?
Influenza A Virus, H1N1 Subtype
3
2015
156
0.470
 Why?
Encephalitis
1
2017
142
0.470
 Why?
Graft vs Host Disease
1
2018
263
0.460
 Why?
Encephalomyelitis, Acute Disseminated
1
2015
11
0.450
 Why?
Neonatal Sepsis
1
2015
8
0.440
 Why?
Immunocompromised Host
5
2021
202
0.440
 Why?
Central Nervous System Viral Diseases
4
2019
78
0.440
 Why?
Herpes Simplex
4
2017
98
0.430
 Why?
Influenza Vaccines
3
2015
530
0.430
 Why?
Antifungal Agents
5
2024
150
0.420
 Why?
Disease Outbreaks
6
2019
423
0.410
 Why?
Neuromyelitis Optica
1
2015
137
0.390
 Why?
CD4 Lymphocyte Count
8
2022
277
0.390
 Why?
Placenta
6
2000
781
0.380
 Why?
Adolescent
37
2024
22409
0.380
 Why?
Child, Preschool
28
2024
11790
0.370
 Why?
Humans
89
2024
144667
0.370
 Why?
Drug Discovery
1
2013
153
0.370
 Why?
Measles Vaccine
1
2012
19
0.370
 Why?
Infant, Newborn
25
2018
6399
0.370
 Why?
Neuromuscular Diseases
3
2019
146
0.370
 Why?
Infant
27
2024
10023
0.370
 Why?
Mucormycosis
3
2005
18
0.360
 Why?
RNA, Viral
12
2013
689
0.340
 Why?
Meningococcal Vaccines
2
2012
57
0.330
 Why?
Cardiovirus Infections
2
2000
3
0.330
 Why?
Female
62
2024
78304
0.320
 Why?
Male
53
2024
72431
0.320
 Why?
Viral Vaccines
2
2009
107
0.310
 Why?
Candidemia
2
2023
15
0.310
 Why?
Oxazoles
4
2015
48
0.310
 Why?
Anti-HIV Agents
5
2022
890
0.300
 Why?
Hepatitis B Vaccines
1
2009
42
0.290
 Why?
Viral Load
7
2017
528
0.290
 Why?
AIDS-Related Opportunistic Infections
3
2015
130
0.290
 Why?
Bacterial Vaccines
1
2009
63
0.280
 Why?
Fatigue Syndrome, Chronic
1
2008
19
0.270
 Why?
Pertussis Vaccine
1
2007
24
0.270
 Why?
Communicable Diseases, Emerging
1
2008
39
0.260
 Why?
Poliomyelitis
2
1997
35
0.260
 Why?
Mycetoma
2
2004
6
0.250
 Why?
Immunoglobulins, Intravenous
3
1997
133
0.250
 Why?
Viremia
5
2021
159
0.240
 Why?
Rhinitis
3
2009
169
0.240
 Why?
Fetus
3
2000
800
0.240
 Why?
Antibodies, Viral
5
2022
672
0.210
 Why?
Pregnancy
16
2021
7122
0.210
 Why?
Enterovirus B, Human
3
2001
25
0.210
 Why?
Meningitis, Viral
2
2004
20
0.210
 Why?
Maxillary Sinusitis
2
2004
6
0.210
 Why?
Maus Elberfeld virus
3
1993
5
0.200
 Why?
Anti-Bacterial Agents
3
2013
1928
0.200
 Why?
Cytomegalovirus
2
2016
168
0.190
 Why?
Interferon-gamma
2
2015
781
0.190
 Why?
Acquired Immunodeficiency Syndrome
2
2017
235
0.190
 Why?
Global Health
2
2018
401
0.190
 Why?
Placenta Diseases
2
1995
19
0.180
 Why?
Administration, Intravenous
2
2024
170
0.180
 Why?
Centralized Hospital Services
1
2001
6
0.180
 Why?
Pneumonia, Viral
2
2021
387
0.170
 Why?
Oseltamivir
2
2012
15
0.170
 Why?
Hepatitis, Viral, Human
1
2001
20
0.170
 Why?
Fetal Diseases
3
2000
193
0.170
 Why?
Research Support as Topic
1
2001
79
0.170
 Why?
Colorado
7
2021
4558
0.160
 Why?
United States
13
2021
16018
0.150
 Why?
Ethmoid Sinusitis
1
1999
1
0.150
 Why?
Streptococcus pneumoniae
3
2014
176
0.150
 Why?
Hydrops Fetalis
1
1999
13
0.150
 Why?
Uterine Diseases
1
1999
18
0.150
 Why?
Retrospective Studies
14
2022
17149
0.150
 Why?
Intracranial Hemorrhages
1
2000
101
0.150
 Why?
Embryonic Development
1
2000
123
0.150
 Why?
Drug Resistance, Microbial
1
1999
71
0.150
 Why?
Polymerase Chain Reaction
4
2016
1047
0.150
 Why?
Blood Coagulation Disorders
1
2001
196
0.150
 Why?
Antibodies, Neutralizing
3
2022
341
0.150
 Why?
Biliary Atresia
1
2020
158
0.140
 Why?
Mastoiditis
2
2014
10
0.140
 Why?
Young Adult
14
2017
14122
0.140
 Why?
Treatment Outcome
10
2024
11735
0.140
 Why?
Follow-Up Studies
8
2022
5414
0.140
 Why?
Nervous System Diseases
2
2019
285
0.140
 Why?
Enterovirus D, Human
2
2018
87
0.140
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
2
2009
13
0.140
 Why?
Fluoxetine
1
2018
54
0.140
 Why?
Risk Factors
12
2024
10796
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
835
0.140
 Why?
Arboviruses
1
2017
14
0.130
 Why?
Neurodevelopmental Disorders
1
2021
223
0.130
 Why?
Hospitals, Pediatric
1
2001
557
0.130
 Why?
Nucleic Acid Hybridization
6
1991
186
0.130
 Why?
In Situ Hybridization
4
2000
318
0.130
 Why?
Double-Blind Method
3
2015
2033
0.130
 Why?
Acyclovir
2
2015
96
0.130
 Why?
Disease Transmission, Infectious
1
2018
68
0.130
 Why?
HIV-1
2
2015
897
0.130
 Why?
Allografts
1
2018
150
0.130
 Why?
Antibodies, Monoclonal
2
2022
1505
0.130
 Why?
Sexual Maturation
1
2017
48
0.130
 Why?
Cohort Studies
7
2024
5957
0.130
 Why?
Immunization, Passive
1
1997
88
0.130
 Why?
Endoscopy
1
1999
317
0.120
 Why?
Practice Guidelines as Topic
2
2022
1569
0.120
 Why?
Cytomegalovirus Retinitis
1
2016
22
0.120
 Why?
Clinical Trials as Topic
1
2001
1056
0.120
 Why?
Brain
3
2017
2934
0.120
 Why?
Adoption
1
2016
25
0.120
 Why?
Hyperlipidemias
1
2017
120
0.120
 Why?
DNA, Viral
2
2016
357
0.120
 Why?
Gastrointestinal Diseases
1
2018
217
0.120
 Why?
Nasal Mucosa
2
2009
112
0.120
 Why?
Diagnosis, Differential
2
2017
1501
0.120
 Why?
Mice, Inbred ICR
4
1997
113
0.120
 Why?
Congenital Abnormalities
2
2010
104
0.110
 Why?
Sexually Transmitted Diseases
1
2017
163
0.110
 Why?
Postoperative Complications
2
2016
2950
0.110
 Why?
Lymphocyte Subsets
1
2015
79
0.110
 Why?
Respiratory Syncytial Virus Infections
1
1997
138
0.110
 Why?
Chi-Square Distribution
2
2013
524
0.110
 Why?
Ganciclovir
1
2015
53
0.110
 Why?
Child Development
2
2017
482
0.110
 Why?
Muscle Hypotonia
1
2015
33
0.110
 Why?
Lymphopenia
1
2015
64
0.110
 Why?
Oropharynx
1
2015
46
0.110
 Why?
Cranial Nerve Diseases
1
2015
44
0.110
 Why?
Adenovirus Infections, Human
2
1991
15
0.110
 Why?
Adult
17
2022
40489
0.100
 Why?
Incidence
6
2017
2892
0.100
 Why?
Hearing Loss, Sensorineural
1
2015
73
0.100
 Why?
Beclomethasone
1
1993
8
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Puberty, Delayed
1
2013
10
0.100
 Why?
Rectum
1
2015
183
0.100
 Why?
Mycoses
1
2014
88
0.100
 Why?
Antibody Affinity
1
2013
60
0.100
 Why?
Giant Cells
1
1993
21
0.100
 Why?
Hemagglutination Inhibition Tests
1
2013
38
0.100
 Why?
Liver Transplantation
1
2020
826
0.100
 Why?
Cytomegalovirus Infections
1
2015
205
0.100
 Why?
Chickenpox
1
1993
80
0.090
 Why?
Candida
1
2012
45
0.090
 Why?
Intensive Care Units, Pediatric
1
2015
288
0.090
 Why?
Viral Plaque Assay
1
2012
29
0.090
 Why?
Orthomyxoviridae
1
2012
40
0.090
 Why?
Hospital Design and Construction
1
1992
3
0.090
 Why?
Neutralization Tests
1
2012
76
0.090
 Why?
Aircraft
1
1992
23
0.090
 Why?
CD4-Positive T-Lymphocytes
2
2017
1129
0.090
 Why?
Bacterial Infections
2
2009
247
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
HIV
1
2013
248
0.090
 Why?
Severity of Illness Index
4
2021
2922
0.090
 Why?
Drug Resistance, Viral
1
2012
123
0.090
 Why?
Chlamydia trachomatis
1
1991
49
0.090
 Why?
Gestational Age
4
2015
980
0.090
 Why?
Chorioamnionitis
1
1991
49
0.080
 Why?
Peritoneovenous Shunt
1
1990
1
0.080
 Why?
Maternal-Fetal Exchange
2
2007
169
0.080
 Why?
Meningitis, Aseptic
1
1990
13
0.080
 Why?
Decision Support Techniques
1
2015
461
0.080
 Why?
Poliovirus Vaccine, Oral
1
1990
25
0.080
 Why?
Trophoblasts
1
1993
218
0.080
 Why?
Rimantadine
1
2010
1
0.080
 Why?
Prospective Studies
7
2017
7994
0.080
 Why?
Legionnaires' Disease
1
1990
4
0.080
 Why?
Adamantane
1
2010
18
0.080
 Why?
Poliovirus
1
1990
73
0.080
 Why?
Biomarkers
1
2021
4261
0.080
 Why?
Hepatitis B Antibodies
1
2009
6
0.080
 Why?
Cross Infection
1
1992
263
0.070
 Why?
Meningitis
1
1990
80
0.070
 Why?
T-Lymphocytes
2
2015
1984
0.070
 Why?
Respiratory Tract Infections
3
2016
395
0.070
 Why?
Administration, Oral
3
2012
851
0.070
 Why?
Maxillary Sinus
2
2009
11
0.070
 Why?
Mice
8
2000
18261
0.070
 Why?
Age Factors
4
2017
3329
0.070
 Why?
Mucor
2
2005
6
0.070
 Why?
South Africa
1
2009
265
0.070
 Why?
Evidence-Based Medicine
3
2021
732
0.070
 Why?
Drug Administration Schedule
2
2015
779
0.070
 Why?
Body Fluids
1
1987
71
0.060
 Why?
Reverse Transcriptase Inhibitors
1
2007
87
0.060
 Why?
Aspergillosis
2
2014
24
0.060
 Why?
Acute Kidney Injury
1
2015
869
0.060
 Why?
Virus Diseases
1
2009
218
0.060
 Why?
Mitochondrial Diseases
1
2007
92
0.060
 Why?
Zygomycosis
1
2006
6
0.060
 Why?
Carotid Artery Thrombosis
1
2005
6
0.060
 Why?
Organ Transplantation
1
2009
247
0.060
 Why?
Statistics as Topic
1
2006
284
0.060
 Why?
Chronic Disease
5
2009
1810
0.060
 Why?
Logistic Models
2
2023
2114
0.060
 Why?
Antibodies, Monoclonal, Humanized
2
2022
990
0.060
 Why?
Drug Therapy, Combination
2
2007
1044
0.060
 Why?
International Cooperation
2
2018
197
0.050
 Why?
Scedosporium
1
2004
1
0.050
 Why?
Herpesvirus 7, Human
1
2004
6
0.050
 Why?
Drug Resistance, Fungal
1
2004
7
0.050
 Why?
Roseolovirus Infections
1
2004
8
0.050
 Why?
Herpesvirus 6, Human
1
2004
14
0.050
 Why?
Animals
9
2000
37948
0.050
 Why?
Longitudinal Studies
3
2018
2942
0.050
 Why?
Granulocyte Colony-Stimulating Factor
1
2004
89
0.050
 Why?
Respiratory Syncytial Viruses
2
1997
58
0.050
 Why?
Randomized Controlled Trials as Topic
2
2004
1742
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2004
161
0.050
 Why?
Vaccines, Conjugate
2
2014
59
0.050
 Why?
Infant, Premature, Diseases
2
1997
112
0.050
 Why?
Biological Availability
1
2003
143
0.050
 Why?
Probability
1
2003
309
0.050
 Why?
Risk Assessment
2
2020
3729
0.040
 Why?
Growth Disorders
1
2022
86
0.040
 Why?
Reference Values
1
2003
794
0.040
 Why?
Bacteria, Aerobic
1
2001
7
0.040
 Why?
Case-Control Studies
3
2015
3603
0.040
 Why?
Personnel Staffing and Scheduling
1
2001
98
0.040
 Why?
Disease Models, Animal
3
2000
4539
0.040
 Why?
Drug Combinations
1
2022
393
0.040
 Why?
Income
1
2022
201
0.040
 Why?
Drug Approval
1
2021
91
0.040
 Why?
Prenatal Exposure Delayed Effects
1
2007
641
0.040
 Why?
RNA Probes
2
1991
12
0.040
 Why?
Disseminated Intravascular Coagulation
1
2000
33
0.040
 Why?
United States Food and Drug Administration
1
2021
205
0.040
 Why?
Adenosine Monophosphate
1
2021
86
0.040
 Why?
RNA
2
2022
926
0.040
 Why?
Systemic Inflammatory Response Syndrome
1
2021
95
0.040
 Why?
Alanine
1
2021
170
0.040
 Why?
Necrosis
1
2000
243
0.040
 Why?
Remission Induction
1
2020
309
0.040
 Why?
Picornaviridae Infections
2
1990
53
0.040
 Why?
Otitis Media with Effusion
1
1999
20
0.040
 Why?
Amniotic Fluid
2
1991
79
0.040
 Why?
Cerebrospinal Fluid
2
2004
88
0.040
 Why?
Pharyngitis
1
1999
25
0.040
 Why?
Pseudallescheria
1
1999
3
0.040
 Why?
Fungi
2
2014
161
0.040
 Why?
Zidovudine
2
2010
77
0.040
 Why?
Opportunistic Infections
1
1999
46
0.040
 Why?
Dose-Response Relationship, Drug
1
2003
2019
0.040
 Why?
Time Factors
1
2009
7140
0.030
 Why?
Living Donors
1
2020
281
0.030
 Why?
Chlamydiaceae Infections
1
2017
1
0.030
 Why?
Diabetes Mellitus, Type 1
2
2005
3910
0.030
 Why?
Spinal Cord
1
2000
384
0.030
 Why?
Epidemiological Monitoring
1
2018
69
0.030
 Why?
Nutrition Disorders
1
1997
20
0.030
 Why?
Internationality
1
2018
154
0.030
 Why?
Sex Factors
2
2017
2104
0.030
 Why?
B-Lymphocytes
2
2015
875
0.030
 Why?
Abortion, Spontaneous
1
1997
115
0.030
 Why?
Antigens, Viral
1
2017
182
0.030
 Why?
Ophthalmoscopy
1
2016
38
0.030
 Why?
Heart
1
2000
626
0.030
 Why?
Otitis Media
1
1999
180
0.030
 Why?
Reoperation
1
1999
624
0.030
 Why?
Encephalomyelitis
1
2016
14
0.030
 Why?
Plasma Cells
2
2009
79
0.030
 Why?
Tissue and Organ Procurement
1
2020
341
0.030
 Why?
Acute Disease
1
1999
1029
0.030
 Why?
Enzyme-Linked Immunospot Assay
1
2015
37
0.030
 Why?
Immune Tolerance
2
1999
381
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Molecular Diagnostic Techniques
1
2016
104
0.030
 Why?
Transplantation, Homologous
1
2016
407
0.030
 Why?
Caribbean Region
1
2015
30
0.030
 Why?
Multicenter Studies as Topic
1
1997
408
0.030
 Why?
North America
1
2016
312
0.030
 Why?
Encephalitis, Varicella Zoster
1
2015
16
0.030
 Why?
Encephalitis, Herpes Simplex
1
2015
21
0.030
 Why?
Biopsy
3
2009
1079
0.030
 Why?
Patient Outcome Assessment
1
2016
132
0.030
 Why?
Audiometry
1
2015
35
0.030
 Why?
Physical Conditioning, Animal
1
1997
241
0.030
 Why?
Latin America
1
2015
95
0.030
 Why?
Evaluation Studies as Topic
1
1995
164
0.030
 Why?
Malnutrition
1
2016
86
0.030
 Why?
Odds Ratio
1
2017
1076
0.030
 Why?
Coinfection
1
2016
141
0.030
 Why?
C-Reactive Protein
1
2017
420
0.030
 Why?
Hematologic Neoplasms
1
2016
163
0.030
 Why?
Microscopy, Electron
1
1995
413
0.030
 Why?
Evoked Potentials, Auditory, Brain Stem
1
2015
50
0.030
 Why?
Combined Modality Therapy
3
2005
1268
0.030
 Why?
Canada
1
2015
432
0.030
 Why?
Neutropenia
1
2015
155
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Infusions, Intravenous
1
2015
422
0.030
 Why?
Multivariate Analysis
1
2017
1537
0.030
 Why?
Papillomavirus Vaccines
1
2017
295
0.020
 Why?
Administration, Intranasal
1
1993
93
0.020
 Why?
Sexual Behavior
1
2017
493
0.020
 Why?
Papillomavirus Infections
1
2017
342
0.020
 Why?
Sequence Analysis, DNA
1
2016
828
0.020
 Why?
T-Lymphocyte Subsets
1
2015
412
0.020
 Why?
Mortality
1
2015
377
0.020
 Why?
Epidemiologic Studies
1
2012
68
0.020
 Why?
Prognosis
1
2001
4312
0.020
 Why?
Oncology Service, Hospital
1
1992
15
0.020
 Why?
Electromyography
1
2015
416
0.020
 Why?
Pandemics
1
2021
1700
0.020
 Why?
Neisseria meningitidis
1
2012
23
0.020
 Why?
Infant, Premature
1
1997
614
0.020
 Why?
Meningococcal Infections
1
2012
26
0.020
 Why?
Tomography, X-Ray Computed
2
1999
2754
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Ventilation
1
1992
46
0.020
 Why?
Amniocentesis
1
1991
20
0.020
 Why?
Mycoplasma Infections
1
1991
17
0.020
 Why?
Microbial Viability
1
2012
91
0.020
 Why?
Europe
1
2012
419
0.020
 Why?
Flow Cytometry
1
2015
1154
0.020
 Why?
Adenoviruses, Human
1
1991
26
0.020
 Why?
Hospitals, University
1
1991
176
0.020
 Why?
Lymphocyte Activation
1
2015
1124
0.020
 Why?
Respirovirus Infections
1
1990
14
0.020
 Why?
Comorbidity
1
2016
1652
0.020
 Why?
Anti-Infective Agents
1
2013
242
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
Aged, 80 and over
1
2023
8284
0.020
 Why?
Immunohistochemistry
1
1995
1705
0.020
 Why?
Chlamydia Infections
1
1991
79
0.020
 Why?
Benzoxazines
1
2010
31
0.020
 Why?
Rhinovirus
1
1990
60
0.020
 Why?
Cyclopropanes
1
2010
83
0.020
 Why?
Legionella
1
1990
9
0.020
 Why?
Alkynes
1
2010
66
0.020
 Why?
Cells, Cultured
1
1997
4110
0.020
 Why?
Population Surveillance
1
1993
484
0.020
 Why?
Sensitivity and Specificity
1
1995
1995
0.020
 Why?
Leukemia
1
1992
245
0.020
 Why?
Dermatomyositis
1
1989
24
0.020
 Why?
Inpatients
1
2014
547
0.020
 Why?
Hospitals
1
2014
729
0.020
 Why?
Peroxidase
1
2009
167
0.020
 Why?
Staining and Labeling
1
2009
153
0.020
 Why?
Natural Killer T-Cells
1
2009
67
0.020
 Why?
Muscles
1
1989
332
0.020
 Why?
Magnetic Resonance Imaging
2
2015
3888
0.020
 Why?
Respiratory Tract Diseases
1
1990
175
0.020
 Why?
Picornaviridae
1
1988
18
0.020
 Why?
Seasons
1
1990
556
0.020
 Why?
Ribonucleases
1
1987
49
0.020
 Why?
Central Nervous System
1
2010
279
0.020
 Why?
HIV Reverse Transcriptase
1
2007
31
0.020
 Why?
Lamivudine
1
2007
65
0.020
 Why?
Telencephalon
1
2005
16
0.010
 Why?
Cavernous Sinus
1
2005
16
0.010
 Why?
Antigens, CD
1
2009
552
0.010
 Why?
Orbit
1
2005
66
0.010
 Why?
Infectious Disease Transmission, Vertical
1
2007
193
0.010
 Why?
Paranasal Sinuses
1
2005
81
0.010
 Why?
Cross-Sectional Studies
1
2016
5870
0.010
 Why?
Exocrine Glands
1
2004
5
0.010
 Why?
Basement Membrane
1
2004
31
0.010
 Why?
Cell Count
1
2004
320
0.010
 Why?
Prevalence
1
2010
2839
0.010
 Why?
Neutrophils
1
2009
1118
0.010
 Why?
Lymphocytes
1
2004
379
0.010
 Why?
Eosinophils
1
2004
316
0.010
 Why?
Penicillin Resistance
1
2001
9
0.010
 Why?
Macrophages
1
2009
1496
0.010
 Why?
beta-Lactamases
1
2001
52
0.010
 Why?
Staphylococcus
1
2001
75
0.010
 Why?
Drug Resistance, Multiple, Bacterial
1
2001
81
0.010
 Why?
Haemophilus influenzae
1
2001
67
0.010
 Why?
Drug Resistance, Bacterial
1
2001
205
0.010
 Why?
Nasal Decongestants
1
1999
8
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
38
0.010
 Why?
Steroids
1
1999
159
0.010
 Why?
Recurrence
1
1999
1136
0.010
 Why?
Anti-Inflammatory Agents
1
1999
477
0.010
 Why?
Patient Selection
1
1999
727
0.010
 Why?
RNA, Antisense
1
1988
18
0.000
 Why?
DNA, Recombinant
1
1988
48
0.000
 Why?
Sequence Homology, Nucleic Acid
1
1988
156
0.000
 Why?
Virus Replication
1
1988
525
0.000
 Why?
Aged
1
2006
25955
0.000
 Why?
Middle Aged
1
2006
35971
0.000
 Why?
Cell Line
1
1988
2821
0.000
 Why?
DNA
1
1988
1447
0.000
 Why?
Abzug's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (408) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)